An effect of treprostinil on stroke volume index (SVI) and multi-point pulmonary artery pressure-flow (PF) in patients with advanced treatment naive pulmonary arterial hypertension.

Trial Profile

An effect of treprostinil on stroke volume index (SVI) and multi-point pulmonary artery pressure-flow (PF) in patients with advanced treatment naive pulmonary arterial hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Treprostinil (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2016 New trial record
    • 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top